Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Circulation. 2012 Nov 26;127(1):96–103. doi: 10.1161/CIRCULATIONAHA.112.136101

Figure 2.

Figure 2

Group mean ± SD of creatine kinase (CK; top) and alanine aminotransferase (ALT; bottom) before (Pre) and after (Post) 6 months of atorvastatin (ATOR) or placebo (PL) treatment with brackets indicating the p value for group-by-time interaction. *Significant difference between groups within a timepoint at p <0.05.